Harpagoside-induced anaphylactic reaction in an IgE-independent manner both in vitro and in vivo
BACKGROUND: Harpagoside (HAR) is an active component of Scrophularia ningpoensis (SN), which has anti-inflammatory and anti-immune effects. SN is used widely in China to treat various diseases. Recently, SN has been used as a traditional Chinese medicine injection and used clinically. However, allergic responses to these injections are frequently reported.
AIM: We examined whether the main component of SN, HAR, is associated with the allergic reaction to SN.
METHODS: This study assessed the effects of HAR in mice and mast cell activation to characterize its anaphylactic effects and underlying mechanisms. Mice hindpaw swelling, serum allergy factor detection, enzyme-linked immunosorbent assays, and degranulation assays were performed to measure allergic mediators both in vivo and in vitro.
RESULTS: The present study indicated that HAR induced paw swelling, interleukin-6, inositol triphosphate, tumor necrosis factor-α, and histamine increases in mice. Our in vitro data also showed that HAR induced β-hexosaminidase, inositol triphosphate, and interleukin-6 release, leading to mast cell degranulation. In contrast, neither C48/80 nor HAR induced local anaphylaxis in STOCK KitW-sh/HNihrJaeBsmJNju mice.
CONCLUSIONS: HAR is a potential sensitization compound in SN, and these results provide information for the safe clinical use of SN.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
Immunopharmacology and immunotoxicology - 40(2018), 2 vom: 15. Apr., Seite 173-178 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Che, Delu [VerfasserIn] |
---|
Links: |
---|
Themen: |
37341-29-0 |
---|
Anmerkungen: |
Date Completed 29.08.2018 Date Revised 29.08.2018 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/08923973.2018.1424900 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM280167962 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM280167962 | ||
003 | DE-627 | ||
005 | 20231225024719.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/08923973.2018.1424900 |2 doi | |
028 | 5 | 2 | |a pubmed24n0933.xml |
035 | |a (DE-627)NLM280167962 | ||
035 | |a (NLM)29355053 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Che, Delu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Harpagoside-induced anaphylactic reaction in an IgE-independent manner both in vitro and in vivo |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.08.2018 | ||
500 | |a Date Revised 29.08.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Harpagoside (HAR) is an active component of Scrophularia ningpoensis (SN), which has anti-inflammatory and anti-immune effects. SN is used widely in China to treat various diseases. Recently, SN has been used as a traditional Chinese medicine injection and used clinically. However, allergic responses to these injections are frequently reported | ||
520 | |a AIM: We examined whether the main component of SN, HAR, is associated with the allergic reaction to SN | ||
520 | |a METHODS: This study assessed the effects of HAR in mice and mast cell activation to characterize its anaphylactic effects and underlying mechanisms. Mice hindpaw swelling, serum allergy factor detection, enzyme-linked immunosorbent assays, and degranulation assays were performed to measure allergic mediators both in vivo and in vitro | ||
520 | |a RESULTS: The present study indicated that HAR induced paw swelling, interleukin-6, inositol triphosphate, tumor necrosis factor-α, and histamine increases in mice. Our in vitro data also showed that HAR induced β-hexosaminidase, inositol triphosphate, and interleukin-6 release, leading to mast cell degranulation. In contrast, neither C48/80 nor HAR induced local anaphylaxis in STOCK KitW-sh/HNihrJaeBsmJNju mice | ||
520 | |a CONCLUSIONS: HAR is a potential sensitization compound in SN, and these results provide information for the safe clinical use of SN | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a IgE-independent | |
650 | 4 | |a Scrophularia ningpoensis | |
650 | 4 | |a anaphylactoid reaction | |
650 | 4 | |a harpagoside | |
650 | 4 | |a mast cell | |
650 | 7 | |a Glycosides |2 NLM | |
650 | 7 | |a Pyrans |2 NLM | |
650 | 7 | |a Immunoglobulin E |2 NLM | |
650 | 7 | |a 37341-29-0 |2 NLM | |
650 | 7 | |a harpagoside |2 NLM | |
650 | 7 | |a 8KGS1DC5ZU |2 NLM | |
700 | 1 | |a Cao, Jiao |e verfasserin |4 aut | |
700 | 1 | |a Liu, Rui |e verfasserin |4 aut | |
700 | 1 | |a Wang, Jue |e verfasserin |4 aut | |
700 | 1 | |a Hou, Yajing |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Tao |e verfasserin |4 aut | |
700 | 1 | |a Wang, Nan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Immunopharmacology and immunotoxicology |d 1996 |g 40(2018), 2 vom: 15. Apr., Seite 173-178 |w (DE-627)NLM012646636 |x 1532-2513 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2018 |g number:2 |g day:15 |g month:04 |g pages:173-178 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/08923973.2018.1424900 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 40 |j 2018 |e 2 |b 15 |c 04 |h 173-178 |